tiprankstipranks
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market
LSTA
Lisata Therapeutics
RESEARCH TOOLSreports

Lisata Therapeutics (LSTA) Financial Statements

Compare
1,052 Followers

Lisata Therapeutics Financial Overview

Lisata Therapeutics's market cap is currently $45.34M. The company's EPS TTM is $-0.334; its P/E ratio is -0.97; Lisata Therapeutics is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 170.00K$ 1.00M$ 0.00$ 0.00$ 0.00
Gross Profit$ 24.00K$ 1.00M$ 0.00$ 0.00$ 0.00
Operating Income$ -18.21M$ -22.41M$ -25.71M$ -57.60M$ -29.05M
EBITDA$ -18.06M$ -22.23M$ -25.52M$ -57.53M$ -29.00M
Net Income$ -16.59M$ -19.98M$ -20.84M$ -54.23M$ -27.47M
Balance Sheet
Cash & Short-Term Investments$ 15.96M$ 31.25M$ 50.53M$ 69.23M$ 94.97M
Total Assets$ 17.74M$ 35.00M$ 54.69M$ 73.03M$ 97.01M
Total Debt$ 0.00$ 137.00K$ 168.00K$ 485.00K$ 714.00K
Net Debt$ -15.96M$ -16.07M$ -22.43M$ -31.67M$ -23.93M
Total Liabilities$ 3.14M$ 5.68M$ 6.80M$ 6.71M$ 5.01M
Stockholders' Equity$ 14.86M$ 29.57M$ 48.15M$ 66.58M$ 92.25M
Cash Flow
Free Cash Flow$ -15.98M$ -19.36M$ -20.03M$ -21.45M$ -22.30M
Operating Cash Flow$ -15.95M$ -19.36M$ -20.03M$ -21.17M$ -22.25M
Investing Cash Flow$ 15.09M$ 13.23M$ 10.10M$ 28.91M$ -54.90M
Financing Cash Flow$ 599.00K$ -206.00K$ 385.00K$ -224.00K$ 85.28M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

Income Statement >

Lisata Therapeutics Debt to Assets

Balance Sheet >

Lisata Therapeutics Cash Flow

Cash Flow >

Lisata Therapeutics Forecast EPS vs Actual EPS

Earnings >